GT Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2010 | $5.7M | $185.0K | $54.0K |
| FY2011 | $5.2M | $129.0K | $92.0K |
| FY2012 | $6.6M | $226.0K | $61.0K |
| FY2013 | $6.5M | $147.0K | $43.0K |
| FY2014 | $30.5M | $888.0K | $855.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2010 | $5.7M | $185.0K | $54.0K |
| FY2011 | $5.2M | $129.0K | $92.0K |
| FY2012 | $6.6M | $226.0K | $61.0K |
| FY2013 | $6.5M | $147.0K | $43.0K |
| FY2014 | $30.5M | $888.0K | $855.0K |